-
Projected Rapid-Growing Economic Burden of Chronic Respiratory Multimorbidity in Singapore: Unveiling Diagnostic Gaps and Asian Phenotypes Through Health Administrative Data
Sep 9, 2025, 16:22 PM -
Generalizability of a Randomized Clinical Trial-Based Prediction Model in a Real-World Population
Sep 9, 2025, 16:22 PM -
Fezolinetant Veoza™ As a Nonhormonal Treatment for Moderate to Severe Vasomotor Symptoms in Postmenopausal Women: A Systematic Literature Review and Meta-Analysis
Sep 9, 2025, 16:22 PM -
Identification of Clusters of Patients With Similar Baseline Characteristics in the FOCAL-MS2 Study Evaluating Patient’s Autonomy
Sep 9, 2025, 16:22 PM -
Real-World Burden of Illness in Patients With ER+/HER2- ABC Receiving Second-Line Treatment: Interim Results of Longitudinal Health Utility Data
Sep 9, 2025, 16:22 PM -
Gatekeepers of Science: Evolving Publishing Policies in the Age of AI
Sep 9, 2025, 16:22 PM -
The Estimation of Utility Weights From the Rett Syndrome Behavior Questionnaire
Sep 9, 2025, 16:22 PM -
A Layered Approach to Reducing Hallucinations in LLMs for Structured and Unstructured Clinical Data
Sep 9, 2025, 16:22 PM -
Quantifying the Fiscal Value of Prevention Programs for Depression
Sep 9, 2025, 16:22 PM -
Quo Vadis? The Emerging Role of the Medicines and Healthcare Products Regulatory Agency (MHRA) in an Evolving Regulatory Landscape
Sep 9, 2025, 16:22 PM -
The Association of Glucagon-Like Peptide-1 Receptor Agonists With Hepatopancreatobiliary Diseases in Individuals With Type 2 Diabetes Mellitus
Sep 9, 2025, 16:22 PM -
Small Molecules vs. Biologics Patterns of Indication Expansion and the Potential Impact of Medicare Price Negotiation
Sep 9, 2025, 16:22 PM -
Cost-Effectiveness Analysis of Pembrolizumab in Combination With Enfortumab Vendotin for First-Line Treatment of Previously Untreated Locally Advanced or Metastatic Urothelial Carcinoma
Sep 9, 2025, 16:22 PM -
Network Meta-Analysis for an Efficacy Assessment of Avelumab Axitinib in the First-Line Treatment of International Metastatic RCC Database Consortium (IMDC) Favorable Risk Patients With Advanced Renal Cell Carcinoma (ARCC)
Sep 9, 2025, 16:22 PM -
Importance of Adjudication Committees in Retrospective Chart Review Studies for Outcomes Event Data Collection
Sep 9, 2025, 16:22 PM -
Budget Impact Analysis of Introducing Nirsevimab Into the National Immunization Program for Infants in Korea
Sep 9, 2025, 16:22 PM -
Trends in Receipt of Preventive Healthcare Services from 2020-2024: US Electronic Health Records (EHR) Database Analysis of 118 Million Patients
Sep 9, 2025, 16:22 PM -
Multimorbidity and Health-Related Quality of Life Among Adult Population in the United States
Sep 9, 2025, 16:22 PM -
Health Economic Evaluation Model for Prostate Cancer Risk Management Through Preimplantation Genetic Testing for Monogenic Disorders (PGT-M)
Sep 9, 2025, 16:22 PM -
Characteristics and Treatment of Prevalent Heart Failure in the US: A Cross-Sectional Analysis of Annual Trends From 2014-2023
Sep 9, 2025, 16:22 PM
